To determine whether type III IFN requires a prolonged treatment to achieve similar antiviral protection as observed with type I IFN, we performed a time course experiment in which human colon organoids were pre-treated for different times with either IFN prior infection with VSV-Luc (Fig 1C). This evidence concerns the gene IFNA1 and infection.